Generalized Anxiety Disorder
📧 Sign up to get email alerts when something new happens for Generalized Anxiety Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-09-20FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for venlafaxine hydrochloride from Dr. Reddy's Laboratories Limited.
-
FDA approval · 2021-09-20FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for a generic escitalopram oxalate product from Rising Pharma Holdings, expanding access to this…
-
FDA approval · 2021-09-20FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Vertical Pharmaceuticals, LLC)
The FDA approved a supplemental application for Venlafaxine hydrochloride from Vertical Pharmaceuticals, LLC.
-
FDA approval · 2021-09-08FDA Approved: ESCITALOPRAM ORAL SOLUTION — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for escitalopram oral solution, adding an approved oral solution formulation for the antidepressant …
-
FDA approval · 2021-09-08FDA Approved: ESCITALOPRAM — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for escitalopram oxalate from Sun Pharmaceutical Industries, Inc., indicating approval of a gene…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-09-03FDA Approved: VENLAFAXINE — Supplemental Application (Cadila Pharmaceuticals Limited)
FDA approved a supplemental application for Venlafaxine from Cadila Pharmaceuticals Limited.
-
FDA approval · 2021-09-03FDA Approved: VENLAFAXINE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for venlafaxine (generic) from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., approv…
-
FDA approval · 2021-09-03FDA Approved: PAROXETINE — Original Application (ANI Pharmaceuticals, Inc.)
ANI Pharmaceuticals received FDA approval for an original ANDA application for paroxetine, a generic antidepressant.
-
FDA approval · 2021-09-02FDA Approved: VENLAFAXINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for venlafaxine by Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2021-08-27FDA Approved: LOREEV XR — Original Application (Almatica Pharma LLC)
The FDA approved LOREEV XR, an extended-release formulation of lorazepam from Almatica Pharma LLC, through an original NDA.
-
FDA approval · 2021-08-27FDA Approved: PAROXETINE — Original Application (Modavar Pharmaceuticals LLC)
FDA approved a generic paroxetine tablet product from Modavar Pharmaceuticals LLC under an original abbreviated new drug application (ANDA 2…
-
FDA approval · 2021-08-06FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Epic Pharma, LLC)
FDA approved the original application for Venlafaxine hydrochloride (generic) manufactured by Epic Pharma, LLC.
-
FDA approval · 2021-08-03FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' supplemental application for escitalopram oxalate, a generic antidepressant product. This constitutes a…
-
FDA approval · 2021-07-23FDA Approved: DRIZALMA SPRINKLE — Supplemental Application (SUN PHARMACEUTICAL INDUSTRIES, INC.)
The FDA approved a supplemental application for Drizalma Sprinkle, a duloxetine product, expanding the label to include a sprinkle-form dosa…
-
FDA approval · 2021-07-15FDA Approved: PREGABALIN — Original Application (Tris Pharma Inc)
The FDA approved Tris Pharma's original Abbreviated New Drug Application for pregabalin, allowing a generic pregabalin product to enter the …
-
FDA approval · 2021-06-30FDA Approved: VENLAFAXINE — Original Application (Dr. Reddy's Laboratories Inc.)
FDA approved the original application for venlafaxine from Dr. Reddy's Laboratories, making a generic version of the antidepressant availabl…
-
FDA approval · 2021-06-16FDA Approved: ALPRAZOLAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Alprazolam from Hikma Pharmaceuticals USA Inc. (generic alprazolam).
-
FDA approval · 2021-06-10FDA Approved: VENLAFAXINE — Original Application (Ascend Laboratories, LLC)
FDA approved a generic venlafaxine product from Ascend Laboratories, LLC under Original Application (ANDA).
-
FDA approval · 2021-04-13FDA Approved: PREGABALIN — Original Application (Novadoz Pharmaceuticals LLC)
FDA approves the original abbreviated new drug application for pregabalin from Novadoz Pharmaceuticals LLC, enabling a generic version of pr…
-
FDA approval · 2021-03-25FDA Approved: DIAZEPAM — Supplemental Application (Oceanside Pharmaceuticals)
FDA supplemental approval for Diazepam under Oceanside Pharmaceuticals is recorded, confirming the approval of a supplemental application fo…
-
FDA approval · 2021-03-09FDA Approved: DOXEPIN HYDROCHLORIDE — Original Application (Leading Pharma, LLC)
FDA approved the original application for doxepin hydrochloride (generic) from Leading Pharma, LLC, for use in treating depressive disorders…
-
FDA approval · 2021-03-03FDA Approved: BUSPIRONE HCL — Supplemental Application (Advagen Pharma Ltd)
The FDA approved a supplemental application for buspirone hydrochloride (Advagen Pharma Ltd), updating the approval status of this generic p…
-
FDA approval · 2021-03-01FDA Approved: XANAX XR — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for XANAX XR (alprazolam) filed by Viatris Specialty LLC.
-
FDA approval · 2021-02-16FDA Approved: PAROXETINE — Original Application (Westminster Pharmaceuticals, LLC)
The FDA approved Westminster Pharmaceuticals' generic paroxetine (PAROXETINE) via an Original Application (ANDA213485). It covers indication…
-
FDA approval · 2021-02-09FDA Approved: BUSPIRONE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approves a supplemental application for buspirone hydrochloride from Mylan Pharmaceuticals Inc. This is an ANDA-related approval for a g…